Tim O’Brien
128 works · 5,811 citations · h-index 29
Top works
- Different angiogenic pathways characterize superficial and invasive bladder cancer.
- Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
- Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial)
- Robotic-assisted Laparoscopic Radical Cystectomy with Extracorporeal Urinary Diversion: Initial Experience
- Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
- Vascular Endothelial Growth Factor is a Predictor of Relapse and Stage Progression in Superficial Bladder Cancer
- Regulation of E-cadherin Expression by VHL and Hypoxia-Inducible Factor
- Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
- Defining the Learning Curve for Percutaneous Nephrolithotomy
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers.
- “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now
- The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
- Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette‐Guérin
- Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
- Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
- Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
- Comorbidity Assessment in Localized Prostate Cancer: A Review of Currently Available Techniques
- Outpatient laser ablation of non‐muscle‐invasive bladder cancer: is it safe, tolerable and cost‐effective?
- Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer.